Geoffrey Dusheiko
- Hepatology top 0.01%
- Epidemiology top 0.02%
- Infectious Diseases top 0.5%
- Immunology top 1%
- Molecular Biology top 10%
- Co-authors
- Rachel WestbrookJean–Michel PawlotskyDavid J. BrownHeiner WedemeyerAlessio AghemoMassimo PuotiFrancesco NegroMarina Berenguer
- Topics
- Hepatitis C virus research (235 papers)Hepatitis B Virus Studies (191 papers)Liver Disease Diagnosis and Treatment (149 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Geoffrey Dusheiko
277 papers receiving 18.0k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Hepatology 15.1k
- Epidemiology 14.6k
- Infectious Diseases 2.4k
- Immunology 1.6k
- Molecular Biology 1.1k
Countries citing papers authored by Geoffrey Dusheiko
This map shows the geographic impact of Geoffrey Dusheiko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Dusheiko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Dusheiko more than expected).
Fields of papers citing papers by Geoffrey Dusheiko
This network shows the impact of papers produced by Geoffrey Dusheiko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Dusheiko. The network helps show where Geoffrey Dusheiko may publish in the future.
Co-authorship network of co-authors of Geoffrey Dusheiko
This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Dusheiko. A scholar is included among the top collaborators of Geoffrey Dusheiko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Dusheiko. Geoffrey Dusheiko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 31 | |
| 4 | 4 | |
| 5 | 26 | |
| 6 | FINAL RESULTS OF ENABLE 1, A PHASE 3, MULTICENTER STUDY OF ELTROMBOPAG AS AN ADJUNCT FOR ANTIVIRAL TREATMENT OF HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASE ASSOCIATED WITH THROMBOCYTOPENIA | 12 |
| 7 | 48 | |
| 8 | 12 | |
| 9 | 133 | |
| 10 | 3 | |
| 11 | 5 | |
| 12 | 241 | |
| 13 | Distinct functional patterns of HBV-specific CD8+cell response in hepatitis B virus infection | 1 |
| 14 | 3 | |
| 15 | 57 | |
| 16 | Predictive factors of histological outcome in posttransplant HCV infection. | 2 |
| 17 | Progress towards the comprehensive control of hepatitis B : proceedings of a roundtable meeting held in Windsor, Berkshire, UK, on 25-26 July 1995 | 1 |
| 18 | RESULTS OF A PLACEBO-CONTROLLED STUDY OF RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS-C | 6 |
| 19 | 15 | |
| 20 | 28 |
About Geoffrey Dusheiko
Geoffrey Dusheiko is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 285 papers that have together received 18.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (235 papers), Hepatitis B Virus Studies (191 papers) and Liver Disease Diagnosis and Treatment (149 papers). The work is most often cited by research in Hepatology (15.1k citations), Epidemiology (14.6k citations) and Infectious Diseases (2.4k citations). Geoffrey Dusheiko has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Rachel Westbrook, Jean–Michel Pawlotsky, David J. Brown, Heiner Wedemeyer, Alessio Aghemo, Massimo Puoti, Francesco Negro, Marina Berenguer, Olav Dalgård and Paul Klenerman. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.